Joseph M. Miller
2018
In 2018, Joseph M. Miller earned a total compensation of $673K as Chief Financial Officer, Principal Executive Officer and Principal Financial Officer at Avalo Therapeutics.
Compensation breakdown
| Bonus | $61,370 |
|---|---|
| Option Awards | $255,515 |
| Salary | $153,600 |
| Stock Awards | $202,500 |
| Total | $672,985 |
Miller received $255.5K in option awards, accounting for 38% of the total pay in 2018.
Miller also received $61.4K in bonus, $153.6K in salary and $202.5K in stock awards.
Rankings
In 2018, Joseph M. Miller's compensation ranked 10,874th out of 14,244 executives tracked by ExecPay. In other words, Miller earned more than 23.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,874 out of 14,244 | 24th |
Division Manufacturing | 4,383 out of 5,759 | 24th |
Major group Chemicals And Allied Products | 1,652 out of 2,122 | 22nd |
Industry group Drugs | 1,401 out of 1,811 | 23rd |
Industry Pharmaceutical Preparations | 1,076 out of 1,385 | 22nd |
Source: SEC filing on June 19, 2019.
Miller's colleagues
We found six more compensation records of executives who worked with Joseph M. Miller at Avalo Therapeutics in 2018.
2018
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
2018
Mariam Morris
Avalo Therapeutics
Chief Financial Officer
2018
James Harrell
Avalo Therapeutics
Executive Vice President, Marketing and External Communications
2018
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
2018
Robert Moscato
Avalo Therapeutics
Chief Operating Officer
2018
Simon Pedder
Avalo Therapeutics